Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

1 ML Sufentanil 0.05 MG/ML Injection

Known as: SUFENTANIL CITRATE 0.05 mg in 1 mL EPIDURAL INJECTION, SUFENTANIL CITRATE 50 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION [Sufentanil Citrate]_#1, Sufentanil Citrate 50 ug in 1 mL INTRAVENOUS INJECTION_#1 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Background and objective This prospective, randomised double-blind study compared the effects of target control infusion (TCI) of… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Sufentanil and remifentanil are characterized by two different pharmacokinetic profiles. The aim of this study was to… Expand
  • figure 3
Is this relevant?
2003
2003
We have evaluated the chemical and microbiological stability of sufentanil citrate, levobupivacaine hydrochloride and a mixture… Expand
Is this relevant?
1998
1998
PURPOSE: There is controversy about relevant EEG signal changes indicating adequate or inadequate anaesthesia. Differences of… Expand
Is this relevant?
1997
1997
This study investigated factors that influence the placental transfer of sufentanil using the dual-perfused, single-cotyledon… Expand
Is this relevant?
1997
1997
UNLABELLED The purpose of our study was to find out whether patient-controlled epidural administration (PCEA) of a mixture… Expand
Is this relevant?
1996
1996
Measurement of motor evoked responses to transcranial electrical stimulation (tc-MER) is a technique for intraoperative… Expand
Is this relevant?
1996
1996
ZusammenfassungIn der prospektiven randomisierten Doppelblindstudie wurden 62 Patienten der ASA-Klassen I–II in zwei Gruppen… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Background Measurement of motor evoked responses to transcranial stimulation (tc-MER) is a technique for intra-operative… Expand
Is this relevant?
1988
1988
A filter-associated binding technique, originally described by Leysen and Gommeren [J. Receptor Res. 4, 817 (1984); Drug Dev. Res… Expand
Is this relevant?